Skip to main content
. Author manuscript; available in PMC: 2021 Jan 20.
Published in final edited form as: Cell Rep. 2020 Dec 22;33(12):108530. doi: 10.1016/j.celrep.2020.108530

Figure 3. Loss of BST2 Prevents IFNγ-Mediated Relocalization.

Figure 3.

(A and B) Representative imaging of WT versus Bst2−/− HSCs before or 24 h after systemic treatment with IFNγ. Data are representative of 2 independent experiments with total n = 39–61 cells per group and were analyzed by Kruskal-Wallace one-way analysis of variance. Mean distances: WT control, 1.72 μm, n = 61; WT IFNγ, 4.40 μm, n = 41; BST2 knockout (KO) control, 2.80 μm, n = 56; BST2 KO IFNγ, 3.18 μm, n = 39. **p < 0.01. Scale bars are 10μm; ns, not significant; error bars represent mean ± SD.